GGrantIndex
← Leaderboards

David T Woodley

University Of Southern California

$8,753,993
Attributed
$11,659,351
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.5M · FY200522
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$11,659,351 · 4
VA$0 · 1

By mechanism

R01$7,994,214 · 2
RC4$3,084,337 · 1
R21$580,800 · 1
I01$0 · 1

Top collaborators

Most similar at University Of Southern California

Same institution · by research overlap

Others in their field

Top investigators on “Keratinocyte

Research focus

KeratinocyteWound HealingFibroblastsSkinWoundDermalGrantHealingCellsCicatrixProteinsIn VivoTopical ApplicationDiabetes MellitusHypoxiaProtein IsoformsDecubitus UlcerPublishingCell MotilityFundingDermisBullaEpidermolysis Bullosa DystrophicaGrowth Factor

Grant awards (37)

The Role of Exogenous Type VII Collagen on the Healing of Skin Wounds$0
I01 · FY2022 · VA · contact PI
The Role of Exogenous Type VII Collagen on the Healing of Skin Wounds$0
I01 · FY2021 · VA · contact PI
The Role of Exogenous Type VII Collagen on the Healing of Skin Wounds$0
I01 · FY2020 · VA · contact PI
A Pilot Study of the Effect of Intravenous Gentamicin on the Restoration of Full-Length Type VII Collagen in RDEB Patients Carrying Nonsense Mutations$290,400
R21 · FY2019 · AR
The Role of Exogenous Type VII Collagen on the Healing of Skin Wounds$0
I01 · FY2019 · VA · contact PI
A Pilot Study of the Effect of Intravenous Gentamicin on the Restoration of Full-Length Type VII Collagen in RDEB Patients Carrying Nonsense Mutations$290,400
R21 · FY2018 · AR
Re-epithelialization of Skin Wounds$0
I01 · FY2017 · VA · contact PI
Re-epithelialization of Skin Wounds$0
I01 · FY2016 · VA · contact PI
Re-epithelialization of Skin Wounds$0
I01 · FY2015 · VA · contact PI
Re-epithelialization of Skin Wounds$0
I01 · FY2014 · VA · contact PI
Purification of Epidermolysis Bullosa Antigen$431,080
R01 · FY2012 · AR · contact PI
Purification of Epidermolysis Bullosa Antigen$431,241
R01 · FY2011 · AR · contact PI
Protein Therapy for Recessive Dystrophic Epidermolysis Bullosa$3,084,337
RC4 · FY2010 · AR
Purification of Epidermolysis Bullosa Antigen$435,763
R01 · FY2010 · AR · contact PI
Purification of Epidermolysis Bullosa Antigen$429,709
R01 · FY2009 · AR · contact PI
Mechanism of Keratinocyte Motility$333,218
R01 · FY2009 · AR · contact PI
Purification of Epidermolysis Bullosa Antigen$172,786
R01 · FY2009 · AR · contact PI
Mechanism of Keratinocyte Motility$333,218
R01 · FY2008 · AR · contact PI
Purification of Epidermolysis Bullosa Antigen$245,000
R01 · FY2008 · AR · contact PI
Mechanism of Keratinocyte Motility$340,018
R01 · FY2007 · AR · contact PI
PURIFICATION OF EPIDERMOLYSIS BULLOSA ANTIGEN$334,222
R01 · FY2007 · AR · contact PI
Mechanism of Keratinocyte Motility$349,994
R01 · FY2006 · AR · contact PI
PURIFICATION OF EPIDERMOLYSIS BULLOSA ANTIGEN$344,204
R01 · FY2006 · AR · contact PI
PURIFICATION OF EPIDERMOLYSIS BULLOSA ANTIGEN$381,875
R01 · FY2005 · AR
Mechanism of Keratinocyte Motility$357,500
R01 · FY2005 · AR
PURIFICATION OF EPIDERMOLYSIS BULLOSA ANTIGEN$381,875
R01 · FY2004 · AR
PURIFICATION OF EPIDERMOLYSIS BULLOSA ANTIGEN$380,700
R01 · FY2003 · AR
MECHANISMS OF KERATINOCYTE MOTILITY$340,348
R01 · FY2003 · AR
MECHANISMS OF KERATINOCYTE MOTILITY$332,730
R01 · FY2002 · AR
PURIFICATION OF EPIDERMOLYSIS BULLOSA ANTIGEN$286,853
R01 · FY2002 · AR
MECHANISMS OF KERATINOCYTE MOTILITY$24,916
R01 · FY2002 · AR
MECHANISMS OF KERATINOCYTE MOTILITY$326,001
R01 · FY2001 · AR
PURIFICATION OF EPIDERMOLYSIS BULLOSA ANTIGEN$280,262
R01 · FY2001 · AR
MECHANISMS OF KERATINOCYTE MOTILITY$74,903
R01 · FY2001 · AR
MECHANISMS OF KERATINOCYTE MOTILITY$320,110
R01 · FY2000 · AR
PURIFICATION OF EPIDERMOLYSIS BULLOSA ANTIGEN$275,547
R01 · FY2000 · AR
MECHANISMS OF KERATINOCYTE MOTILITY$50,141
R01 · FY2000 · AR